Collectively, we obtained eight overlapped markers from different techniques and defined them as the HCC-CSMs, including NOX4, BIRC5, E2F1, CD34, KIF2C, AURKA, CDK1, and GMNN (Supplementary Tables S3–S5). This evidence concerns the gene E2F1 and hepatocellular carcinoma.